EcoDrugPlus

Ensembl ID : YJL001W
Description: -
165 Possible Orthologues:

Title

Ensembl ID : YJL093C
Description: -
174 Possible Orthologues:

Title

Ensembl ID : YJL136C
Description: -
83 Possible Orthologues:

Title

Ensembl ID : YJL164C
Description: -
229 Possible Orthologues:

Title

Ensembl ID : YJL167W
Description: -
101 Possible Orthologues:

Title

Ensembl ID : YJL177W
Description: -
128 Possible Orthologues:

Title

Ensembl ID : YJL190C
Description: -
104 Possible Orthologues:

Title

Ensembl ID : YJL191W
Description: -
107 Possible Orthologues:

Title

Ensembl ID : YJL216C
Description: -
322 Possible Orthologues:

Title

Ensembl ID : YJL221C
Description: -
322 Possible Orthologues:

Title

Ensembl ID : YJR123W
Description: -
117 Possible Orthologues:

Title

Ensembl ID : YJR126C
Description: -
199 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).